ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
122.350,38
0,00%
S&P 500
5.996,66
1,00%
US Dollar vs BRL
6,0684
-0,20%
Bitcoin
106.207,03
3,00%
Brent Oil
79,855
-0,45%
As Melhores Corretoras Online
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Vivos Therapeutics Inc (VVOS)

  7. Vivos Therapeutics Inc (VVOS) Notícias

VVOS

Vivos Therapeutics (VVOS)

Vivos Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:VVOS
DataHoraFonteTítuloCódigoCompanhia
26/12/202409:06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:VVOSVivos Therapeutics Inc
23/12/202419:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VVOSVivos Therapeutics Inc
23/12/202410:00GlobeNewswire Inc.Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:VVOSVivos Therapeutics Inc
20/12/202417:17Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:VVOSVivos Therapeutics Inc
27/11/202418:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VVOSVivos Therapeutics Inc
14/11/202418:05Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:VVOSVivos Therapeutics Inc
14/11/202418:05GlobeNewswire Inc.Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational UpdateNASDAQ:VVOSVivos Therapeutics Inc
13/11/202419:00GlobeNewswire Inc.Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference CallNASDAQ:VVOSVivos Therapeutics Inc
06/11/202418:15Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:VVOSVivos Therapeutics Inc
08/10/202408:30GlobeNewswire Inc.Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical AssociationNASDAQ:VVOSVivos Therapeutics Inc
24/09/202415:59Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:VVOSVivos Therapeutics Inc
19/09/202408:00GlobeNewswire Inc.Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq RulesNASDAQ:VVOSVivos Therapeutics Inc
18/09/202418:15AllPennyStocks.comHealthcare Shares Pop On FDA ClearanceNASDAQ:VVOSVivos Therapeutics Inc
18/09/202408:00GlobeNewswire Inc.Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and SnoringNASDAQ:VVOSVivos Therapeutics Inc
14/08/202417:24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VVOSVivos Therapeutics Inc
14/08/202417:05GlobeNewswire Inc.Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational UpdateNASDAQ:VVOSVivos Therapeutics Inc
14/08/202408:30GlobeNewswire Inc.Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference CallNASDAQ:VVOSVivos Therapeutics Inc
08/08/202418:19Edgar (US Regulatory)Form 424B1 - Prospectus [Rule 424(b)(1)]NASDAQ:VVOSVivos Therapeutics Inc
08/08/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VVOSVivos Therapeutics Inc
30/07/202407:17Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:VVOSVivos Therapeutics Inc
27/06/202408:30GlobeNewswire Inc.Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution ModelNASDAQ:VVOSVivos Therapeutics Inc
12/06/202408:30GlobeNewswire Inc.Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution AllianceNASDAQ:VVOSVivos Therapeutics Inc
20/05/202414:04GlobeNewswire Inc.Consolidated Water Comments on ISS and Glass Lewis Reports and Urges Stockholders to Vote “FOR” Re-Election of Its Highly Qualified DirectorsNASDAQ:VVOSVivos Therapeutics Inc
14/05/202417:05GlobeNewswire Inc.Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational UpdateNASDAQ:VVOSVivos Therapeutics Inc
14/05/202408:30GlobeNewswire Inc.Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference CallNASDAQ:VVOSVivos Therapeutics Inc
09/04/202408:30GlobeNewswire Inc.Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare ReimbursementNASDAQ:VVOSVivos Therapeutics Inc
28/03/202417:05GlobeNewswire Inc.Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational UpdateNASDAQ:VVOSVivos Therapeutics Inc
28/03/202408:30GlobeNewswire Inc.Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference CallNASDAQ:VVOSVivos Therapeutics Inc
15/02/202410:00GlobeNewswire Inc.Vivos Therapeutics Announces Exercise of Warrants for Approximately $4.0 Million Aggregate Gross ProceedsNASDAQ:VVOSVivos Therapeutics Inc
14/02/202419:42Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VVOSVivos Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:VVOS

Seu Histórico Recente

TG
A19HDS
Flughafen Zrich
TG
A3K1M1
National Bank of Canada
TG
LAGB
Lagardere SCA
NASDAQ
CFFPX
Ci Mosaic Esg Balanced G...
LSE
0RAB
Cnova Nv
TG
A289NU
Amphenol Technologies
TG
A3KT9V
Goldman Sachs
BOV
CSRN3
COSERN ON
TG
A3K2B2
Nordea Bank Abp
TG
F1RA
France
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados